Retaglutide is a innovative GLP-1 receptor agonist currently under research for the management of type 2 diabetes. This medication works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally https://aliciadyel255976.activablog.com/38084260/trelaglutide-exploring-a-new-treatment-for-chronic-diseases